Agostini Massimiliano, Ganini Carlo, Candi Eleonora, Melino Gerry
1Department of Experimental Medicine, TOR, University of Rome "Tor Vergata", 00133 Rome, Italy.
2IDI-IRCCS, Via Monti di Creta 106, 00166 Rome, Italy.
Cell Death Discov. 2020 Mar 12;6:13. doi: 10.1038/s41420-020-0247-6. eCollection 2020.
Regulatory noncoding RNAs (ncRNAs) are a class of RNAs transcribed by regions of the human genome that do not encode for proteins. The three main members of this class, named microRNA, long noncoding RNA, and circular RNA play a key role in the regulation of gene expression, eventually shaping critical cellular processes. Compelling experimental evidence shows that ncRNAs function either as tumor suppressors or oncogenes by participating in the regulation of one or several cancer hallmarks, including evading cell death, and their expression is frequently deregulated during cancer onset, progression, and dissemination. More recently, preclinical and clinical studies indicate that ncRNAs are potential biomarkers for monitoring cancer progression, relapse, and response to cancer therapy. Here, we will discuss the role of noncoding RNAs in regulating cancer cell death, focusing on those ncRNAs with a potential clinical relevance.
调控性非编码RNA(ncRNAs)是一类由人类基因组中不编码蛋白质的区域转录而来的RNA。这类RNA的三个主要成员,即微小RNA、长链非编码RNA和环状RNA,在基因表达调控中发挥关键作用,最终塑造关键的细胞过程。有力的实验证据表明,ncRNAs通过参与对一个或多个癌症标志(包括逃避细胞死亡)的调控,发挥肿瘤抑制因子或癌基因的作用,并且它们的表达在癌症发生、发展和扩散过程中经常失调。最近,临床前和临床研究表明,ncRNAs是监测癌症进展、复发和对癌症治疗反应的潜在生物标志物。在此,我们将讨论非编码RNA在调节癌细胞死亡中的作用,重点关注那些具有潜在临床相关性的ncRNAs。